Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$194K Sell
11,088
-1,713
-13% -$31.4K ﹤0.01% 685
2017
Q1
$229K Sell
12,801
-819
-6% -$13.2K ﹤0.01% 655
2016
Q4
$202K Buy
13,620
+2,986
+28% +$45.2K ﹤0.01% 690
2016
Q3
$165K Sell
10,634
-286
-3% -$4.08K ﹤0.01% 677
2016
Q2
$137K Sell
10,920
-544
-5% -$6.77K ﹤0.01% 635
2016
Q1
$141K Buy
11,464
+1,257
+12% +$13.4K ﹤0.01% 629
2015
Q4
$121K Sell
10,207
-10,760
-51% -$138K ﹤0.01% 599
2015
Q3
$244K Sell
20,967
-5,149
-20% -$66.9K ﹤0.01% 524
2015
Q2
$356K Buy
26,116
+51
+0.2% +$757 0.01% 493
2015
Q1
$369K Buy
26,065
+1,740
+7% +$28.7K 0.01% 470
2014
Q4
$443K Sell
24,325
-2,436
-9% -$40.8K 0.01% 432
2014
Q3
$431K Buy
26,761
+727
+3% +$11.8K 0.01% 443
2014
Q2
$398K Buy
26,034
+12,351
+90% +$186K 0.01% 468
2014
Q1
$201K Sell
13,683
-4,028
-23% -$54.2K ﹤0.01% 567
2013
Q4
$225K Buy
+17,711
New +$203K ﹤0.01% 447

Other funds holding HPQ

Geneva Advisors's HPQ Position: Q2 2017 in Review

Geneva Advisors reduced its HP (HPQ) stake by 13% in Q2 2017, selling an estimated $31.4K and leaving 11,088 shares worth $194K. The position accounts for ﹤0.01% of the portfolio, ranked #685.

Geneva Advisors first reported a position in HPQ in Q4 2013 and has held it in 15 quarters since. The position peaked at $443K in Q4 2014. 823 funds tracked by Wall St. Rank hold HPQ as of Q2 2017.

  • Geneva Advisors held 11,088 shares of HP worth $194K as of Q2 2017.
  • Geneva Advisors sold 1,713 HP shares in Q2 2017, an estimated $31.4K.
  • HP made up ﹤0.01% of Geneva Advisors's portfolio in Q2 2017, its #685 holding.
  • Geneva Advisors first reported a position in HP in Q4 2013 and has held it in 15 quarters since.
  • Geneva Advisors's HP position peaked at $443K in Q4 2014.
  • 823 funds tracked by Wall St. Rank held HP as of Q2 2017.

Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.